GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

TableEdit

Jump to: navigation, search

PMID:21057534

You don't have sufficient rights on this wiki to edit tables. Perhaps you need to log in. Changes you make in the Table editor will not be saved back to the wiki

See Help for Help on this wiki. See the documentation for how to use the table editor

Citation

Pittoni, P, Piconese, S, Tripodo, C and Colombo, MP (2011) Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors. Oncogene 30:757-69

Abstract

c-Kit tyrosine kinase receptor and its ligand stem cell factor have multiple functions during development, whereas in adulthood they are mostly needed for stem cell (SC) maintenance and mast cell (MC) biology. c-Kit plays an essential tumor-cell-intrinsic role in many types of cancer, either providing the tumorigenic force when aberrantly activated or conferring stem-like features characterizing the most aggressive variants. A tumor-cell-extrinsic role occurs through c-Kit-dependent accessory cells (such as MCs) that infiltrate tumors and deeply influence their progression. c-Kit-targeted therapy with tyrosine kinase inhibitors (TKIs) may ideally work against both tumor and stromal cells. Here, we summarize the tumor-intrinsic and -extrinsic roles of c-Kit in cancer and discuss TKIs with their on- and off-targets, with a special emphasis on MCs as paradigmatic c-Kit-dependent accomplices for tumor progression.

Links

PubMed Online version:10.1038/onc.2010.494

Keywords

Animals; Antineoplastic Agents/therapeutic use; Humans; Mast Cells/drug effects; Mast Cells/immunology; Mast Cells/metabolism; Mastocytosis/blood supply; Mastocytosis/drug therapy; Mastocytosis/immunology; Mice; Neoplasm Invasiveness; Neoplasms/blood supply; Neoplasms/drug therapy; Neoplasms/enzymology; Neovascularization, Pathologic/drug therapy; Neovascularization, Pathologic/enzymology; Protein Kinase Inhibitors/therapeutic use; Proto-Oncogene Proteins c-kit/antagonists & inhibitors; Proto-Oncogene Proteins c-kit/metabolism; Rats; Stem Cell Factor/metabolism

public



Cancel